Attitudes to mesalamine questionnaire: A novel tool to predict mesalamine nonadherence in patients with IBD

American Journal of Gastroenterology

Volumn 109, Issue 12, 2014, Pages 1850-1855

  Moss, Alan C ^a   Lillis, Yvonne ^a   Edwards George, Jessica B ^b   Choudhry, Niteesh K ^a   Berg, Anders H ^a   Cheifetz, Adam S ^a   Horowitz, Gary ^a   Leffler, Dan A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALICYLIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH BELIEF; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT REFUSAL; ULCERATIVE COLITIS; URINE LEVEL; ATTITUDE TO HEALTH; COHORT ANALYSIS; COLITIS, ULCERATIVE; MAINTENANCE CHEMOTHERAPY; MIDDLE AGED; PSYCHOLOGY; SELF REPORT; URINE; YOUNG ADULT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; ATTITUDE TO HEALTH; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; MAINTENANCE CHEMOTHERAPY; MALE; MEDICATION ADHERENCE; MESALAMINE; MIDDLE AGED; QUESTIONNAIRES; SALICYLATES; SELF REPORT; YOUNG ADULT;

EID: 84925227196     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.158     Document Type: Article

References (37)

1. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006; 23: 577-85.
2. Moody GA, Jayanthi V, Probert CS et al. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996; 8: 1179-83.
3. Kane SV, Cohen RD, Aikens JE et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001; 96: 2929-33.
4. Higgins PD, Rubin DT, Kaulback K et al. Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009; 29: 247-57.
5. Kane S, Huo D, Aikens J et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003; 114: 39-43.
6. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci 2008; 53: 1020-4.
7. Cerveny P, Bortlik M, Kubena A et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007; 13: 1244-9.
8. Ediger JP, Walker JR, Graff L et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007; 102: 1417-26.
9. Horne R, Parham R, Driscoll R et al. Patients ' attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 837-44.
10. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol 2013; 4: 91.
11. Cook PF, Emiliozzi S, El Hajj D et al. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns 2010; 81: 182-6.
12. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007; 167: 540-50.
13. Moss AC, Chaudhary N, Tukey M et al. Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis-A prospective study. J Crohn's Colitis 2010; 4: 171-5.
14. Moshkovska T, Stone M, Baker R et al. Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis. Inflamm Bowel Dis 2008; 14: 763-8.
15. Vrijens B, De Geest S, Hughes DA et al. A new taxonomy for describing and defi ning adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705.
16. Devlen J, Beusterein K, Yen L et al. Factors influencing adherence to mesalamine in patients with inflammatory bowel disease: a patientreported qualitative analysis. J Manag Care Pharm 2014; 20: 309-14.
17. Garfield S, Clifford S,eliasson L et al. Suitability of measures of selfreported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol 2011; 11: 149.
18. Morisky DE, Ang A, Krousel-Wood M et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich.) 2008; 10: 348-54.
19. Trindade AJ, Ehrlich A, Kornbluth A et al. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2011; 17: 599-604.
20. Shi L, Liu J, Koleva Y et al. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics 2010; 28: 1097-107.
21. Trindade AJ, Morisky DE, Ehrlich AC et al. Current practice and perception of screening for medication adherence in inflammatory bowel disease. J Clin Gastroenterol 2011; 45: 878-82.
22. Gifford AE, Berg AH, Lahiff C et al. A random urine test can identify patients at risk of mesalamine non-adherence: a prospective study. Am J Gastroenterol 2013; 108: 249-55.
23. Leffler DA, Dennis M, Edwards George JB et al. A simple validated glutenfree diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 2009; 7: 530-6.
24. Kane S, Becker B, Harmsen WS et al. Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease. Am J Gastroenterol 2012; 107: 154-60.
25. Walmsley RS, Ayres RC, Pounder RE et al. A simple clinical colitis activity index. Gut 1998; 43: 29-32.
26. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996; 91: 1571-8.
27. Farid NA, Born GS, Kessler WV et al. Improved colorimetric determination of salicylic acid and its metabolites in urine. Clin Chem 1975; 21: 1167-8.
28. Hess LM, Raebel MA, Conner DA et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard defi nitions and preferred measures. Ann Pharmacother 2006; 40: 1280-8.
29. Krousel-Wood M, Islam T, Webber LS et al. New medication adherence scale versus pharmacy fi ll rates in seniors with hypertension. Am J Manag Care 2009; 15: 59-66.
30. Horne R, Weinman J. Patients ' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-67.
31. Chambers SA, Raine R, Rahman A et al. Why do patients with systemic lupus erythematosus take or fail to take their prescribed medications? A qualitative study in a UK cohort. Rheumatology (Oxford) 2009; 48: 266-71.
32. Linn AJ, van Dijk L, Smit EG et al. May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease. J Crohns Colitis 2013; 7: e543-50.
33. Wouters H, van Geffen EC, Baas-Thijssen MC et al. Disentangling breast cancer patients ' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence. Breast 2013; 22: 661-6.
34. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients ' perspectives on medication-related problems. Patient Educ Couns 2007; 65: 407-15.
35. Ediger JP, Walker JR, Graff L et al. Assessing changes in reported medication adherence over a three year period: the Manitoba IBD Cohort Study. Gastroenterology 2009; 136: A679-80 (Abstract).
36. Moshkovska T, Stone MA, Smith RM et al. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis 2011; 17: 1874-81.
37. Vervloet M, van Dijk L, Santen-Reestman J et al. Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients ' medication use combined with short message service (SMS) reminders. BMC Health Serv Res 2011; 11: 5.